Home・Listă Acțiuni・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Închisă

SectorSănătate

1.56 11.43

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.3900000000000001

Maxim

1.47

Indicatori cheie
By Trading Economics
Venit	-45M -53M
Vânzări	1.8M 39M
EPS	-0.14
Marjă de profit	-135.914
Angajați	485
EBITDA	-32M -38M

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	+34.75% upside

Dividende
By Acuity
Următoarele câștiguri	4 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-18M 423M
Deschiderea anterioară	-9.87
Închiderea anterioară	1.56

Sentimentul știrilor

By Acuity

50%

128 / 339 Clasament în Healthcare

Pacific Biosciences of California Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 sept. 2026, 20:07 UTC

Correlated Moves

Pacific Biosciences is sharply lower, following a broader market decline and significant losses in key holdings of the ARK Genomic Revolution ETF.

22 sept. 2026, 23:06 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, having declined from earlier gains and remaining above its 20-day moving average.

21 sept. 2026, 22:35 UTC

In after-market trading, Pacific Biosciences of California Inc is roughly flat since Monday's close, reflecting routine performance near the lower end of its one-month range.

18 sept. 2026, 23:51 UTC

Pacific Biosciences of California Inc declined during after-market trading, moving lower since Friday's close and currently below its 20-day moving average.

17 sept. 2026, 20:02 UTC

Macro Event

Correlated Moves

Pacific Biosciences is sharply higher, reflecting a positive trend in the life sciences sector, alongside gains in the ARK Genomic Revolution ETF.

16 sept. 2026, 23:16 UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, remaining below its 20-day moving average after four consecutive higher sessions.

15 sept. 2026, 23:11 UTC

Pacific Biosciences of California is gaining in after-market trading, supported by a positive performance backdrop and four consecutive higher closes.

14 sept. 2026, 20:05 UTC

Correlated Moves

Pacific Biosciences of California is higher today, influenced by social media discussions on Tempus AI's $80 price target and broader market sentiment.

11 sept. 2026, 19:02 UTC

Pacific Biosciences of California is trading higher, continuing its recovery after three sessions of declines. No specific news was identified for the upward movement.

9 sept. 2026, 20:01 UTC

News

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.

8 sept. 2026, 23:56 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

3 sept. 2026, 19:56 UTC

Pacific Biosciences of California is lower today with no specific news. The broader market sees falling Treasury yields amid jobless claims data.

2 sept. 2026, 23:46 UTC

Pacific Biosciences of California is higher in after-market trading, despite no specific news, amid a weaker ADP payrolls report that may ease rate hike concerns.

1 sept. 2026, 23:46 UTC

Pacific Biosciences of California remained roughly flat during after-market hours. This follows five consecutive sessions of lower finishes.

31 aug. 2026, 20:07 UTC

Pacific Biosciences is trading lower, reflecting broader market declines amid heightened interest rate hike expectations from the Jackson Hole Economic Symposium.

28 aug. 2026, 23:36 UTC

Pacific Biosciences is trading higher in after-market hours, reaching a level significantly above Friday's close amid broader market pressures from rising Treasury yields.

27 aug. 2026, 20:07 UTC

Pacific Biosciences of California is lower today, with no specific news driving the decline. The broader market has also been down since Wednesday.

26 aug. 2026, 23:06 UTC

Pacific Biosciences of California traded roughly flat in after-market hours, with no specific news driving the activity. The stock remains near its one-month range's upper end.

25 aug. 2026, 23:01 UTC

Pacific Biosciences is lower in after-market trading, with no specific news identified. The broader market has also retreated amid falling crude oil prices.

24 aug. 2026, 23:01 UTC

Pacific Biosciences of California is trading higher in after-hours, recovering from an initial low and remaining above its 20-day moving average.

21 aug. 2026, 22:51 UTC

Correlated Moves

Shares of Pacific Biosciences of California declined in after-market trading, continuing a downward trend amid broader market weakness and rising Treasury yields.

20 aug. 2026, 19:51 UTC

Correlated Moves

Pacific Biosciences is lower today, reflecting broader market declines and trading near the lower end of its one-month range.

19 aug. 2026, 23:11 UTC

Correlated Moves

Pacific Biosciences of California shows a modest increase in after-market trading, reflecting stability amid a broader positive trend in correlated assets.

18 aug. 2026, 23:16 UTC

Correlated Moves

Pacific Biosciences shares declined in after-hours trading, continuing a downward trend since Tuesday's close, amid broader market sentiment reflected by the Russell 2000 Index.

17 aug. 2026, 19:11 UTC

News

Pacific Biosciences reported second-quarter revenue of $39 million, with shares trading higher today after initially dropping. The company is undergoing a leadership transition.

14 aug. 2026, 19:36 UTC

Correlated Moves

News

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 aug. 2026, 23:06 UTC

Correlated Moves

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 aug. 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 aug. 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 aug. 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.

Comparație

Modificare preț

Pacific Biosciences of California Inc Așteptări

Obiectiv de preț

By TipRanks

34.75% sus

Prognoză pe 12 luni

Medie 1.9 USD 34.75%

Maxim 3 USD

Minim 1.25 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPacific Biosciences of California Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor Pacific Biosciences of California Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

128 / 339 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.